Position in CRDF
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$84,751
-$3,286 QoQ
Shares Held
52,316
+67.0% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,301,022,166 across 256 Biotechnology names. CRDF ranks #242 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in CRDF
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $84,751 | 52,316 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $88,037 | 31,330 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $64,539 | 31,330 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $94,950 | 30,143 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $78,999 | 25,159 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $66,792 | 15,390 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $131,462 | 49,237 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $109,306 | 49,237 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $194,910 | 36,500 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $54,020 | 36,500 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $50,735 | 36,500 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $53,655 | 36,500 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $60,225 | 36,500 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $51,100 | 36,500 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $56,210 | 36,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $80,300 | 36,500 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $53,270 | 21,480 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $124,286 | 20,680 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $9,527,989 | 529,627 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,852,164 | 553,359 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||